Pharmaceutical Affairs Act Article 29
Manufacturers of western pharmaceuticals shall have a full-time resident pharmacist to supervise the manufacturing. Manufacturers of Chinese medicines shall have a full-time resident Chinese medicine doctor or a pharmacist who has received training in Chinese medicines to an appropriate level to supervise the manufacturing.In addition to the provisions of the preceding paragraph, if a manufacturer of Chinese medicines plans to manufacture Chinese medicines in the form of western pharmaceuticals or to adulterate western pharmaceuticals in Chinese medicines, there shall be an additional full-time pharmacist to supervise the manufacturing.The provisions of the preceding two paragraphs shall also apply to the case where a manufacturer of either western pharmaceuticals or Chinese medicines intends to set up a separate branch factory.
中文原文 藥事法第29條
西藥製造業者，應由專任藥師駐廠監製；中藥製造業者，應由專任中醫師或修習中藥課程達適當標準之藥師駐廠監製。
中藥製造業者，以西藥劑型製造中藥，或摻入西藥製造中藥時，除依前項規定外，應由專任藥師監製。
西藥、中藥製造業者，設立分廠，仍應依前二項規定辦理。
中藥製造業者，以西藥劑型製造中藥，或摻入西藥製造中藥時，除依前項規定外，應由專任藥師監製。
西藥、中藥製造業者，設立分廠，仍應依前二項規定辦理。